Anti-angiogenic therapy

Anti-angiogenic therapy is a treatment strategy that targets the process by which tumors create new blood vessels, called angiogenesis, to supply themselves with nutrients and oxygen. By inhibiting this process, the therapy aims to starve the tumor, slowing or stopping its growth. This approach involves medications that block specific signals or factors (like VEGF) essential for new blood vessel formation. It’s used in cancer treatment to control tumor growth, often in combination with other therapies, providing a way to target the tumor’s support system rather than the cancer cells directly.